These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23726980)

  • 1. Changing patterns of first injection across key periods of the French Harm Reduction Policy: PrimInject, a cross sectional analysis.
    Guichard A; Guignard R; Michels D; Beck F; Arwidson P; Lert F; Roy E
    Drug Alcohol Depend; 2013 Nov; 133(1):254-61. PubMed ID: 23726980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
    Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
    Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a harm-reduction policy on HIV and hepatitis C virus transmission among drug users: recent French data--the ANRS-Coquelicot Study.
    Jauffret-Roustide M; Emmanuelli J; Quaglia M; Barin F; Arduin P; Laporte A; Desenclos JC
    Subst Use Misuse; 2006; 41(10-12):1603-21. PubMed ID: 17002994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
    Emmanuelli J; Desenclos JC
    Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges and opportunities to integrating family members of injection drug users into harm reduction efforts within the Atlantic Canadian context.
    Jackson LA; Dykeman M; Gahagan J; Karabanow J; Parker J
    Int J Drug Policy; 2011 Sep; 22(5):385-92. PubMed ID: 21742479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
    Duburcq A; Charpak Y; Blin P; Madec L
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of measures taken in France to reduce the risks of heroin addiction via intravenous route].
    Henrion R
    Bull Acad Natl Med; 1997; 181(6):1177-85; discussion 1186-9. PubMed ID: 9453840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors Associated with Unsafe Injection Practices at the First Injection Episode among Intravenous Drug Users in France: Results from PrimInject, an Internet Survey.
    Guichard A; Guignard R; Lert F; Roy E
    J Addict; 2015; 2015():507214. PubMed ID: 26504609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From political controversy to a technical problem? Fifteen years of opioid substitution treatment in Finland.
    Selin J; Hakkarainen P; Partanen A; Tammi T; Tigerstedt C
    Int J Drug Policy; 2013 Nov; 24(6):e66-72. PubMed ID: 24095679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users seeking treatment over an 11-year period and harm reduction policy.
    Fatseas M; Denis C; Serre F; Dubernet J; Daulouède JP; Auriacombe M
    AIDS Behav; 2012 Oct; 16(7):2082-90. PubMed ID: 21983799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of substance use and correlates of lifetime and active injection drug use among women in Malaysia.
    Wickersham JA; Loeliger KB; Marcus R; Pillai V; Kamarulzaman A; Altice FL
    Am J Drug Alcohol Abuse; 2016; 42(1):98-110. PubMed ID: 26636885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risks incurred by the first intravenous drug injection].
    Varescon I; Vidal-Trécan G; Gagnière B; Christoforov B; Boissonnas A
    Ann Med Interne (Paris); 2000 Oct; 151 Suppl B():B5-8. PubMed ID: 11221691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users.
    Novelli LA; Sherman SG; Havens JR; Strathdee SA; Sapun M
    Drug Alcohol Depend; 2005 Mar; 77(3):303-9. PubMed ID: 15734230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition to injection amongst opioid users in Iran: implications for harm reduction.
    Malekinejad M; Vazirian M
    Int J Drug Policy; 2012 Jul; 23(4):333-7. PubMed ID: 21996166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran.
    Hosseini M; SeyedAlinaghi S; Kheirandish P; Esmaeli Javid G; Shirzad H; Karami N; Jahani M; Seyed Ahmadian M; Payvarmehr F; Mohraz M; Emadi Koochak H; McFarland W
    Arch Iran Med; 2010 Jul; 13(4):318-23. PubMed ID: 20597566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some characteristics of early-onset injection drug users prior to and at the time of their first injection.
    Abelson J; Treloar C; Crawford J; Kippax S; van Beek I; Howard J
    Addiction; 2006 Apr; 101(4):548-55. PubMed ID: 16548934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates.
    Barrio G; Bravo MJ; Brugal MT; Díez M; Regidor E; Belza MJ; de la Fuente L;
    Addiction; 2012 Jun; 107(6):1111-22. PubMed ID: 22151686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs.
    Larance B; Degenhardt L; Copeland J; Dillon P
    Drug Alcohol Rev; 2008 Nov; 27(6):679-86. PubMed ID: 18825549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of human rights violations and perceptions of discrimination on health service utilization among injection drug users in Delhi, India.
    Sarin E; Kerrigan D
    Subst Use Misuse; 2012 Feb; 47(3):230-43. PubMed ID: 22217124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is opioid substitution treatment beneficial if injecting behaviour continues?
    Gjersing L; Bretteville-Jensen AL
    Drug Alcohol Depend; 2013 Nov; 133(1):121-6. PubMed ID: 23773951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.